<DOC>
	<DOCNO>NCT01249183</DOCNO>
	<brief_summary>Primary objective : To demonstrate REPEVAX VAXIGRIP administer concomitantly subject 60 year age old least immunogenic REPEVAX VAXIGRIP administer separately . Secondary objective : •Secondary immunogenicity objective : To describe immune response 28 day concomitant separate administration REPEVAX VAXIGRIP subject 60 year age old To describe immune response VAXIGRIP accord European Medicines Agency criterion subject 60 year age old ( Note Guidance , 1997 : 28 ) •Secondary safety objective : To describe safety profile vaccination group</brief_summary>
	<brief_title>Safety Immunogenicity Study Concomitant Versus Non Concomitant Administration Diphtheria , Tetanus , Pertussis Poliomyelitis Vaccine ( REPEVAX ) Influenza Vaccine ( VAXIGRIP ) Subjects Aged From 60 Years Old</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Tetany</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adults age ≥60 year At least one document booster dose tetanus diphtheriacontaining vaccine 5 15 year No influenza vaccine administer last 6 month Receipt booster dose tetanus diphtheria poliomyelitis contain vaccine within last 5 year Receipt pertussiscontaining vaccine pertussis disease within last 10 year Receipt medication / vaccine may interfere study assessment Febrile illness moderate severe acute illness/infection History hypersensitivity anaphylactic allergic reaction vaccine component , history lifethreatening reaction study vaccine vaccine contain substance History Guillain Barré syndrome brachial neuritis follow previous vaccination History encephalopathy unknown origin within 7 day immunization pertussiscontaining vaccine unstable neurological disorder Known suspected immune dysfunction Thrombocytopenia , bleed disorder anticoagulant contraindicate intramuscular vaccination Chronic disease unstable intercurrent illness might interfere ability participate fully study ; interfere evaluation vaccine</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Pertussis ( acellular , component )</keyword>
	<keyword>Diphteria</keyword>
	<keyword>Biological / vaccine</keyword>
</DOC>